India · Delayed Price · Currency is INR Windlas Biotech Company Description
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India.
The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services.
It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules.
In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies.
It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.
| Country | India |
| Founded | 2001 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,346 |
| CEO | Komal Gupta |
Contact Details
Address: 40/1, Mohabewala Industrial Area Dehradun, Haryana 248 110 India | |
| Phone | 91 135 660 8000 |
| Website | windlas.com |
Stock Details
| Ticker Symbol | 543329 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Komal Gupta | Chief Executive Officer |
| Komal Gupta | Chief Financial Officer |